The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Open accessAbstract
TGF-β1 has been long considered as a key mediator in renal fibrosis and induces renal scarring largely by activating its downstream Smad signaling pathway. Interestingly, while mice overexpressing active TGF-β1 develop progressive renal injury, latent TGF-β1 plays a protective role in renal fibrosis and inflammation. Under disease conditions, Smad2 and Smad3 are highly activated, while Smad7 is degraded through the ubiquitin proteasome degradation mechanism. In addition to TGF-β1, many pathogenic mediators such as angiotensin II and advanced glycation end products can also activate the Smad pathway via both TGF-β-dependent and independent mechanisms. Smads interact with other signaling pathways, such as the MAPK and NF-κB pathways, to positively or negatively regulate renal inflammation and fibrosis. Studies from gene knockout mice demonstrate that TGF-β1 acts by stimulating its downstream Smads to diversely regulate kidney injury. In the context of renal fibrosis and inflammation, Smad3 is pathogenic, while Smad2 and Smad7 are protective. Smad4 exerts its diverse roles by transcriptionally enhancing Smad3-mediated renal fibrosis while inhibiting NF-κB-driven renal inflammation via a Smad7-dependent mechanism. Furthermore, we also demonstrated that TGF-β1 acts by stimulating Smad3 to positively or negatively regulate microRNAs to exert its fibrotic role in kidney disease. In conclusion, TGF-β/Smad signaling is a major pathway leading to kidney disease. Smad3 is a key mediator in renal fibrosis and inflammation, whereas Smad2 and Smad7 are renoprotective. Smad4 exerts its diverse role in promoting renal fibrosis while inhibiting inflammation. Thus, targeting the downstream TGF-β/Smad3 signaling pathway by gene transfer of either Smad7 or Smad3-dependent microRNAs may represent a specific and effective therapeutic strategy for kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205
Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
Lagna, G., Hata, A., Hemmati-Brivanlou, A., & Massagué, J. (1996) · Nature · doi:10.1038/383832a0 · Cited by 905
Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., & Miyazono, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100008200 · Cited by 844
Sato, M., Muragaki, Y., Saika, S., Roberts, A. B., & Ooshima, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19270 · Cited by 831
Li, M. O., Sanjabi, S., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.011 · Cited by 805
Li, M. O., Wan, Y. Y., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.014 · Cited by 733
Sanderson, N., Factor, V, Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., & Thorgeirsson, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2572 · Cited by 671
Verrecchia, F., Chu, M.-L., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664
Lin, X., Liang, M., & Feng, X.-H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000580200 · Cited by 489
Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
Kopp, J. B., Factor, V. M., Mozes, M., Nagy, P., Sanderson, N., Böttinger, E. P., Klotman, P. E., & Thorgeirsson, S. S. (1996) · PubMed · Cited by 422
Wrana, J. L. (2000) · Cell · doi:10.1016/s0092-8674(00)81556-1 · Cited by 421
KANG, D.-H., JOLY, A. H., OH, S.-W., HUGO, C., KERJASCHKI, D., GORDON, K. L., MAZZALI, M., JEFFERSON, J. A., HUGHES, J., MADSEN, K. M., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271434 · Cited by 411
Chen, S.-J., Yuan, W., Mori, Y., Levenson, A., Varga, J., & Trojanowska, M. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00477.x · Cited by 410
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
Self-citationPiek, E., Ju, W. J., Heyer, J., Escalante-Alcalde, D., Stewart, C. L., Weinstein, M., Deng, C., Kucherlapati, R., Böttinger, E. P., & Roberts, A. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102382200 · Cited by 397
Molecular and Cell Biology of TGF-β
Roberts, A. B. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057358 · Cited by 386
miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
Self-citationInduction of Inhibitory Smad6 and Smad7 mRNA by TGF-β Family Members
Afrakhte, M., Morén, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C.-H., Heldin, N.-E., & ten Dijke, P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9170 · Cited by 353
ROBERTS, A., TIAN, F., BYFIELD, S., STUELTEN, C., OOSHIMA, A., SAIKA, S., & FLANDERS, K. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.008 · Cited by 348
Transforming growth factor‐β and Smad signalling in kidney diseases: Review Article
WANG, W., KOKA, V., & LAN, H. Y. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00334.x · Cited by 347
Self-citationmiR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression
Wang, B., Koh, P., Winbanks, C., Coughlan, M. T., McClelland, A., Watson, A., Jandeleit-Dahm, K., Burns, W. C., Thomas, M. C., Cooper, M. E., et al. (2011) · Diabetes · doi:10.2337/db10-0892 · Cited by 345
Lan, H. Y., Mu, W., Tomita, N., Huang, X. R., Li, J. H., Zhu, H.-J., Morishita, R., & Johnson, R. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000067632.04658.b8 · Cited by 344
Self-citationTGF-β in Renal Injury and Disease
Böttinger, E. P. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.009 · Cited by 339
Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
Meng, X. M., Huang, X. R., Chung, A. C. K., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121244 · Cited by 338
Self-citationEpithelial-Specific Cre/lox Recombination in the Developing Kidney and Genitourinary Tract
Shao, X., Somlo, S., & Igarashi, P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016444.90348.50 · Cited by 330
Diabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 289
Self-citationSmad3 Signaling Is Required for Epithelial-Mesenchymal Transition of Lens Epithelium after Injury
Saika, S., Kono-Saika, S., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Flanders, K. C., Yoo, J., Anzano, M., Liu, C.-Y., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63153-7 · Cited by 283
Li, J. H., Huang, X. R., Zhu, H., Oldfield, M., Cooper, M., Truong, L. D., Johnson, R. J., & Lan, H. Y. (2004) · The FASEB Journal · doi:10.1096/fj.02-1117fje · Cited by 264
Self-citationTubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells
Lan, H. Y. (2003) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200301000-00005 · Cited by 259
Self-citationYang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258
Self-citationMembrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg
Stockis, J., Colau, D., Coulie, P. G., & Lucas, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200939684 · Cited by 252
Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells
Wang, R., Kozhaya, L., Mercer, F., Khaitan, A., Fujii, H., & Unutmaz, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901965106 · Cited by 251
Li, J., Qu, X., Yao, J., Caruana, G., Ricardo, S. D., Yamamoto, Y., Yamamoto, H., & Bertram, J. F. (2010) · Diabetes · doi:10.2337/db09-1631 · Cited by 250
Regulation of TGF‐β family signaling by E3 ubiquitin ligases
Inoue, Y., & Imamura, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00925.x · Cited by 246
Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4
Nagarajan, R. P., Zhang, J., Li, W., & Chen, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33412 · Cited by 246
Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., & Lan, H. Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121070 · Cited by 236
Self-citationGeneration of Smad4/Dpc4 conditional knockout mice
Yang, X., Li, C., Herrera, P., & Deng, C. (2002) · genesis · doi:10.1002/gene.10029 · Cited by 235
Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234
Self-citationThe Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Chen, H. Y., Huang, X. R., Wang, W., Li, J. H., Heuchel, R. L., Chung, A. C. K., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db10-0403 · Cited by 225
Self-citationFukasawa, H., Yamamoto, T., Togawa, A., Ohashi, N., Fujigaki, Y., Oda, T., Uchida, C., Kitagawa, K., Hattori, T., Suzuki, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400035101 · Cited by 215
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
Yaswen, L., Kulkarni, A., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., Longenecker, G., Mozes, E., & Karlsson, S. (1996) · Blood · doi:10.1182/blood.v87.4.1439.bloodjournal8741439 · Cited by 204
Chronic Kidney Disease Progression
Eddy, A. A., & Neilson, E. G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070704 · Cited by 200
Abnormal Angiogenesis in Diabetic Nephropathy
Nakagawa, T., Kosugi, T., Haneda, M., Rivard, C. J., & Long, D. A. (2009) · Diabetes · doi:10.2337/db09-0119 · Cited by 199
Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy
Fujimoto, M., Maezawa, Y., Yokote, K., Joh, K., Kobayashi, K., Kawamura, H., Nishimura, M., Roberts, A. B., Saito, Y., & Mori, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00885-4 · Cited by 189
Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner
Verrecchia, F., Vindevoghel, L., Lechleider, R. J., Uitto, J., Roberts, A. B., & Mauviel, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204448 · Cited by 183
Advanced Glycation End-Products Induce Tubular CTGF via TGF-β–Independent Smad3 Signaling
Chung, A. C. K., Zhang, H., Kong, Y.-Z., Tan, J.-J., Huang, X. R., Kopp, J. B., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010018 · Cited by 180
Self-citationVindevoghel, L., Lechleider, R. J., Kon, A., de Caestecker, M. P., Uitto, J., Roberts, A. B., & Mauviel, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14769 · Cited by 179
Dennler, S., Huet, S., & Gauthier, J.-M. (1999) · Oncogene · doi:10.1038/sj.onc.1202729 · Cited by 176
Chung, A. C. K., Huang, X. R., Zhou, L., Heuchel, R., Lai, K. N., & Lan, H. Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn699 · Cited by 175
Self-citationIsono, M., Chen, S., Won Hong, S., Carmen Iglesias-de la Cruz, M., & Ziyadeh, F. N. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02084-3 · Cited by 173
von Gersdorff, G., Susztak, K., Rezvani, F., Bitzer, M., Liang, D., & Böttinger, E. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11320 · Cited by 166
Hou, C., Wang, W., Huang, X. R., Fu, P., Chen, T.-H., Sheikh‐Hamad, D., & Lan, H. Y. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62297-3 · Cited by 158
Self-citationTGF-β induces proangiogenic and antiangiogenic factorsvia parallel but distinct Smad pathways
Nakagawa, T., Li, J., García, G., Mu, W., Piek, E., Böttinger, E. P., Chen, Y., Zhu, H., Kang, D., Schreiner, G. F., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00780.x · Cited by 157
Self-citationDeletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation
Ju, W., Ogawa, A., Heyer, J., Nierhof, D., Yu, L., Kucherlapati, R., Shafritz, D. A., & Böttinger, E. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.654-667.2006 · Cited by 157
Evidence that TGF-β should be a therapeutic target in diabetic nephropathy
Border, W. A., & Noble, N. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00127.x · Cited by 146
Mechanism of chronic aristolochic acid nephropathy: role of Smad3
Zhou, L., Fu, P., Huang, X. R., Liu, F., Chung, A. C. K., Lai, K. N., & Lan, H. Y. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00675.2009 · Cited by 136
Self-citationSmad7 Gene Therapy Ameliorates an Autoimmune Crescentic Glomerulonephritis in Mice
Ka, S., Huang, X., Lan, H.-Y., Tsai, P., Yang, S., Shui, H., & Chen, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080901 · Cited by 123
Self-citationLatent TGF-β1 Protects Against Crescentic Glomerulonephritis
Huang, X. R., Chung, A. C. K., Zhou, L., Wang, X. J., & Lan, H. Y. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040484 · Cited by 120
Self-citationSmad7 as a therapeutic agent for chronic kidney diseases
Lan, H. Y. (2008) · Frontiers in bioscience · doi:10.2741/3057 · Cited by 119
Self-citationTransforming Growth Factor-β and Smads
Lan, H. Y., & Chung, A. C. K. (2011) · Contributions to nephrology · doi:10.1159/000324949 · Cited by 109
Self-citationEssential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition
Yang, F., Huang, X. R., Chung, A. C., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2721 · Cited by 109
Terada, Y., Hanada, S., Nakao, A., Kuwahara, M., Sasaki, S., & Marumo, F. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.0610s1094.x · Cited by 101
Phan, T.-T., Lim, I. J., Aalami, O., Lorget, F., Khoo, A., Tan, E. K., Mukhopadhyay, A., & Longaker, M. T. (2005) · The Journal of Pathology · doi:10.1002/path.1826 · Cited by 97
Schnaper, H. W., Hayashida, T., & Poncelet, A.-C. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341126 · Cited by 96
TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines
Fink, S. P., Mikkola, D. L., Willson, J. K. V., & Markowitz, S. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206128 · Cited by 95
Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease
Huang, X. R., Chung, A. C. K., Wang, X., Lai, K. N., & Lan, H. Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00021.2008 · Cited by 94
Self-citationYang, J., Zhang, X., Li, Y., & Liu, Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000099373.33259.b2 · Cited by 89
Smad7 Differentially Regulates Transforming Growth Factor β-mediated Signaling Pathways
Zhu, H., Iaria, J., & Sizeland, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32258 · Cited by 86
Tan, R., He, W., Lin, X., Kiss, L. P., & Liu, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00323.2007 · Cited by 78
Zhou, Y., Mao, H., Li, S., Cao, S., Li, Z., Zhuang, S., Fan, J., Dong, X., Borkan, S. C., Wang, Y., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050552 · Cited by 67
Blockade of TGF-β Signaling in T Cells Prevents the Development of Experimental Glomerulonephritis
Kanamaru, Y., Nakao, A., Mamura, M., Suzuki, Y., Shirato, I., Okumura, K., Tomino, Y., & Ra, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2818 · Cited by 50
Cited by
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
New insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D.-Q., Wang, Y.-N., Feng, Y.-L., Cao, G., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,179
TGF-β signalling and its role in cancer progression and metastasis
Drabsch, Y., & ten Dijke, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9375-7 · Cited by 428
Diabetic nephropathy and inflammation
Duran-Salgado, M. B. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.393 · Cited by 382
Antar, S. A., Ashour, N. A., Marawan, M. E., & Al-Karmalawy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044004 · Cited by 366
Metadata
- Authors
- Lan, H. Y.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2011
- Volume
- 7
- Issue
- 7
- Pages
- 1056-1067
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2104274897
- Cited by
- 652
- References
- 75
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.